Clinical Trials

South Africa Cholera Vaccine Enters Human Trials

South Africa Cholera Vaccine Enters Human Trials

South Africa has begun Phase 1 trials of a locally manufactured oral cholera vaccine after regulatory approval. The study tests safety in healthy adults at sites in Gauteng, KwaZulu-Natal and the Eastern Cape, aiming to boost regional supply and speed outbreak response
November 13, 2025
Huntington's Disease Treatment Breakthrough

Huntington’s Disease Treatment Breakthrough

A first-of-its-kind gene therapy has slowed Huntington’s disease by targeting the mutant gene that kills brain cells. In a three-year trial of 29 patients, high doses cut progression by up to 75% and reduced cell-death markers, helping some stay mobile or return
September 26, 2025